Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation

Volume: 41 Number: 1 March 1, 2015
  • Yavuz Ayar
  • Alparslan Ersoy
  • Emel İşiktaş Sayılar
  • Abdülmecit Yıldız
  • Firdevs Ulutaş
  • Ahmet Bilgehan Şahin
  • Elif Kır
  • Ahmet Kaya
EN TR

Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation

Abstract

Immunosuppressive therapy is important after transplantation for graft and patient survey. Especially calcineurin inhibitors are one of the most important treatment option after kidney transplantation. After using tacrolimus have been reported many side effects and posterior reversible leukoencephalopathy (PRES) cases are among them. The disease is observed with headache, mental status changes, neurologic dysfunction such as epileptic seizures. Computed tomography and magnetic resonance imaging shows lesions in temporoparietal or occipital region. Symptoms decrease a few days later by reduction or change the drug dose. Herein, a female patients who underwent kidney transp-lantation were presented. Clinical symptoms regressed after changing medication.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Yavuz Ayar This is me

Alparslan Ersoy This is me

Emel İşiktaş Sayılar This is me

Abdülmecit Yıldız This is me

Firdevs Ulutaş This is me

Ahmet Bilgehan Şahin This is me

Elif Kır This is me

Ahmet Kaya This is me

Publication Date

March 1, 2015

Submission Date

March 1, 2015

Acceptance Date

-

Published in Issue

Year 2015 Volume: 41 Number: 1

APA
Ayar, Y., Ersoy, A., Sayılar, E. İ., Yıldız, A., Ulutaş, F., Şahin, A. B., Kır, E., & Kaya, A. (2015). Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation. Journal of Uludağ University Medical Faculty, 41(1), 31-33. https://izlik.org/JA87PH72YA
AMA
1.Ayar Y, Ersoy A, Sayılar Eİ, et al. Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation. Journal of Uludağ University Medical Faculty. 2015;41(1):31-33. https://izlik.org/JA87PH72YA
Chicago
Ayar, Yavuz, Alparslan Ersoy, Emel İşiktaş Sayılar, et al. 2015. “Posterior Reversible Leukoencephalopathy After Tacrolimus Therapy in Renal Transplantation”. Journal of Uludağ University Medical Faculty 41 (1): 31-33. https://izlik.org/JA87PH72YA.
EndNote
Ayar Y, Ersoy A, Sayılar Eİ, Yıldız A, Ulutaş F, Şahin AB, Kır E, Kaya A (March 1, 2015) Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation. Journal of Uludağ University Medical Faculty 41 1 31–33.
IEEE
[1]Y. Ayar et al., “Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation”, Journal of Uludağ University Medical Faculty, vol. 41, no. 1, pp. 31–33, Mar. 2015, [Online]. Available: https://izlik.org/JA87PH72YA
ISNAD
Ayar, Yavuz - Ersoy, Alparslan - Sayılar, Emel İşiktaş - Yıldız, Abdülmecit - Ulutaş, Firdevs - Şahin, Ahmet Bilgehan - Kır, Elif - Kaya, Ahmet. “Posterior Reversible Leukoencephalopathy After Tacrolimus Therapy in Renal Transplantation”. Journal of Uludağ University Medical Faculty 41/1 (March 1, 2015): 31-33. https://izlik.org/JA87PH72YA.
JAMA
1.Ayar Y, Ersoy A, Sayılar Eİ, Yıldız A, Ulutaş F, Şahin AB, Kır E, Kaya A. Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation. Journal of Uludağ University Medical Faculty. 2015;41:31–33.
MLA
Ayar, Yavuz, et al. “Posterior Reversible Leukoencephalopathy After Tacrolimus Therapy in Renal Transplantation”. Journal of Uludağ University Medical Faculty, vol. 41, no. 1, Mar. 2015, pp. 31-33, https://izlik.org/JA87PH72YA.
Vancouver
1.Yavuz Ayar, Alparslan Ersoy, Emel İşiktaş Sayılar, Abdülmecit Yıldız, Firdevs Ulutaş, Ahmet Bilgehan Şahin, Elif Kır, Ahmet Kaya. Posterior Reversible Leukoencephalopathy after Tacrolimus Therapy in Renal Transplantation. Journal of Uludağ University Medical Faculty [Internet]. 2015 Mar. 1;41(1):31-3. Available from: https://izlik.org/JA87PH72YA

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023